The sensitivity of normal brain and intracranially implanted VX2 tumour to interstitial photodynamic therapy.

The applicability and limitations of a photodynamic threshold model, used to describe quantitatively the in vivo response of tissues to photodynamic therapy, are currently being investigated in a variety of normal and malignant tumour tissues. The model states that tissue necrosis occurs when the number of photons absorbed by the photosensitiser per unit tissue volume exceeds a threshold. New Zealand White rabbits were sensitised with porphyrin-based photosensitisers. Normal brain or intracranially implanted VX2 tumours were illuminated via an optical fibre placed into the tissue at craniotomy. The light fluence distribution in the tissue was measured by multiple interstitial optical fibre detectors. The tissue concentration of the photosensitiser was determined post mortem by absorption spectroscopy. The derived photodynamic threshold values for normal brain are significantly lower than for VX2 tumour for all photosensitisers examined. Neuronal damage is evident beyond the zone of frank necrosis. For Photofrin the threshold decreases with time delay between photosensitiser administration and light treatment. No significant difference in threshold is found between Photofrin and haematoporphyrin derivative. The threshold in normal brain (grey matter) is lowest for sensitisation by 5 delta-aminolaevulinic acid. The results confirm the very high sensitivity of normal brain to porphyrin photodynamic therapy and show the importance of in situ light fluence monitoring during photodynamic irradiation.

[1]  M. Moore,et al.  The passage of delta-aminolaevulinic acid across the blood-brain barrier of the rat: effect of ethanol. , 1974, Biochemical pharmacology.

[2]  M. J. Chapman.  Comparative analysis of mammalian plasma lipoproteins. , 1986, Methods in enzymology.

[3]  D. Ash,et al.  In vivo measurement of the optical interaction coefficients of human tumours at 630 nm. , 1991, Physics in medicine and biology.

[4]  A H Kaye,et al.  Selective uptake of hematoporphyrin derivative into human cerebral glioma. , 1990, Neurosurgery.

[5]  Michael S. Patterson,et al.  Dependence of photodynamic threshold dose on treatment parameters in normal rat liver in vivo , 1991, Photonics West - Lasers and Applications in Science and Engineering.

[6]  S. Marcus,et al.  Global status of clinical photodynamic therapy: The registration process for a new therapy , 1992, Lasers in surgery and medicine.

[7]  Brian C. Wilson,et al.  Photodynamic therapy of malignant brain tumours. , 1990 .

[8]  M F Mafee,et al.  Photodynamic therapy in the treatment of squamous cell carcinoma of the head and neck. , 1990, Archives of otolaryngology--head & neck surgery.

[9]  M R Arnfield,et al.  Analysis of tissue optical coefficients using an approximate equation valid for comparable absorption and scattering. , 1992, Physics in medicine and biology.

[10]  C. L. White,et al.  Improved rabbit brain tumor model amenable to diagnostic radiographic procedures. , 1982, Neurosurgery.

[11]  M. Dereski,et al.  DEPTH MEASUREMENTS AND HISTOPATHOLOGICAL CHARACTERIZATION OF PHOTODYNAMIC THERAPY GENERATED NORMAL BRAIN NECROSIS AS A FUNCTION OF INCIDENT OPTICAL ENERGY DOSE , 1991, Photochemistry and photobiology.

[12]  D. Thomas,et al.  Br. J. Cancer Br. J. Cancer (I , 2022 .

[13]  J C Kennedy,et al.  Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. , 1992, Journal of photochemistry and photobiology. B, Biology.

[14]  M. V. van Gemert,et al.  Fluorescence localization in tumour and normal brain after intratumoral injection of haematoporphyrin derivative into rat brain tumour. , 1995, Journal of photochemistry and photobiology. B, Biology.

[15]  E. C. Albritton.  STANDARD VALUES IN BLOOD , 1954 .

[16]  M C Berenbaum,et al.  In vivo biological activity of the components of haematoporphyrin derivative. , 1982, British Journal of Cancer.

[17]  H. Fukuda,et al.  Tumour-localizing properties of porphyrins. In vivo studies using free and liposome encapsulated aminolevulinic acid. , 1992, Comparative biochemistry and physiology. B, Comparative biochemistry.

[18]  S. Brem,et al.  Neovascularization and tumor growth in the rabbit brain. A model for experimental studies of angiogenesis and the blood-brain barrier. , 1988, The American journal of pathology.

[19]  A H Kaye,et al.  Uptake and retention of hematoporphyrin derivative in an in vivo/in vitro model of cerebral glioma. , 1985, Neurosurgery.

[20]  H Anholt,et al.  Sensitizer for photodynamic therapy of cancer: A comparison of the tissue distribution of photofrin ii and aluminum phthalocyanine tetrasulfonate in nude mice bearing a human malignant tumor , 1991, International journal of cancer.

[21]  C. Grosjean,et al.  A high accuracy approximation for solving multiple scattering problems in infinite homogeneous media , 1956 .

[22]  Temperature rise in tumor tissue during high-dose-rate photoradiation. , 1993, Mathematical biosciences.

[23]  OPTICAL AND PHOTOBIOLOGICAL DOSIMETRY FOR PHOTODYNAMIC THERAPY OF SOLID TUMORS , 1992 .

[24]  J. Tulip,et al.  Effects of photoradiation therapy on normal rat brain. , 1984, Neurosurgery.

[25]  S. Stylli,et al.  Evaluation of tumour and tissue distribution of porphyrins for use in photodynamic therapy. , 1992, British Journal of Cancer.

[26]  F. Newell.  Standard Values in Blood , 1952 .

[27]  J. Boggan,et al.  NORMAL BRAIN TISSUE RESPONSE TO PHOTODYNAMIC THERAPY USING ALUMINUM PHTHALOCYANINE TETRASULFONATE IN THE RAT , 1993, Photochemistry and photobiology.

[28]  T. Yoshimoto,et al.  Intratumoral oxygen pressure in malignant brain tumor. , 1991, Journal of neurosurgery.

[29]  L. Kwock,et al.  Stereotactic intratumoral photodynamic therapy for recurrent malignant brain tumors. , 1991, Neurosurgery.

[30]  Lothar Lilge,et al.  Temperature-dependent changes in the optical absorption and scattering spectra of tissues: correlation with ultrastructure , 1993, Photonics West - Lasers and Applications in Science and Engineering.

[31]  M T Tseng,et al.  The effect of photodynamic therapy on the microcirculation. , 1988, The Journal of surgical research.

[32]  Lothar Lilge,et al.  Determination of the photodynamic threshold for normal rabbit brain and for intracranially implanted VX2 tumors , 1993, Photonics West - Lasers and Applications in Science and Engineering.

[33]  A E Profio,et al.  Dosimetry considerations in phototherapy. , 1981, Medical physics.

[34]  M S Patterson,et al.  In vivo TESTS OF THE CONCEPT OF PHOTODYNAMIC THRESHOLD DOSE IN NORMAL RAT LIVER PHOTOSENSITIZED BY ALUMINUM CHLOROSULPHONATED PHTHALOCYANINE , 1990, Photochemistry and photobiology.

[35]  T. Wieman,et al.  THE EFFECTS OF THROMBOXANE INHIBITORS ON THE MICROVASCULAR AND TUMOR RESPONSE TO PHOTODYNAMIC THERAPY , 1993, Photochemistry and photobiology.

[36]  P. Charlesworth,et al.  The use of 5-aminolevulinic acid (ALA) in photodynamic therapy (PDT). , 1993, Journal of photochemistry and photobiology. B, Biology.

[37]  B. Wilson,et al.  A diffusion theory model of spatially resolved, steady-state diffuse reflectance for the noninvasive determination of tissue optical properties in vivo. , 1992, Medical physics.

[38]  M S Patterson,et al.  The use of a neural network to determine tissue optical properties from spatially resolved diffuse reflectance measurements. , 1992, Physics in medicine and biology.

[39]  M Chopp,et al.  EFFECTS OF LIGHT BEAM SIZE ON FLUENCE DISTRIBUTION AND DEPTH OF NECROSIS IN SUPERFICIALLY APPLIED PHOTODYNAMIC THERAPY OF NORMAL RAT BRAIN , 1992, Photochemistry and photobiology.

[40]  J T Brown,et al.  Relation between polyporphyrin distribution and blood brain barrier changes in the rat glioma model , 1992, Lasers in surgery and medicine.

[41]  L. Lilge,et al.  Miniature isotropic optical fibre probes for quantitative light dosimetry in tissue. , 1993, Physics in medicine and biology.

[42]  J. Kennedy,et al.  The possible role of ionic species in selective biodistribution of photochemotherapeutic agents toward neoplastic tissue. , 1990, Journal of photochemistry and photobiology. B, Biology.

[43]  M Chopp,et al.  Photoactivated Photofrin II: Astrocytic Swelling Precedes Endothelial Injury in Rat Brain , 1992, Journal of neuropathology and experimental neurology.

[44]  S. K. Powers,et al.  Toxicity of photodynamic therapy with photofrin in the normal rat brain , 1994, Lasers in surgery and medicine.

[45]  M Chopp,et al.  The effect of light fluence rate in photodynamic therapy of normal rat brain. , 1992, Radiation research.

[46]  J Moan,et al.  PHOTOBLEACHING OF PORPHYRINS USED IN PHOTODYNAMIC THERAPY AND IMPLICATIONS FOR THERAPY , 1987, Photochemistry and photobiology.

[47]  B. Wilson,et al.  An update on the penetration depth of 630 nm light in normal and malignant human brain tissue in vivo. , 1986, Physics in medicine and biology.

[48]  D. Vernon,et al.  The quantitative determination of Photofrin and Polyhaematoporphyrin in plasma: pitfalls and inaccuracies. , 1995, Journal of photochemistry and photobiology. B, Biology.

[49]  William R. Potter,et al.  The Theory Of Photodynamic Therapy Dosimetry: Consequences Of Photodestruction Of Sensitizer , 1987, Other Conferences.

[50]  Lothar Lilge,et al.  Accuracy of interstitial measurements of absolute light fluence rate in the determination of tissue optical properties , 1993, Photonics West - Lasers and Applications in Science and Engineering.

[51]  I Rosenthal,et al.  Release of clotting factors from photosensitized endothelial cells: A possible trigger for blood vessel occlusion by photodynamic therapy , 1988, FEBS letters.

[52]  M. Berns,et al.  Distribution of hematoporphyrin derivative in the rat 9l gliosarcoma brain tumor analyzed by digital video fluorescence microscopy. , 1984, Journal of neurosurgery.

[53]  M. Dereski,et al.  Neuronal injury after photoactivation of photofrin II. , 1992, The American journal of pathology.

[54]  S. K. Powers,et al.  Light dosimetry in brain tissue: An in vivo model applicable to photodynamic therapy , 1986, Lasers in surgery and medicine.

[55]  L. O. Svaasand,et al.  OPTICAL PROPERTIES OF HUMAN BRAIN , 1983, Photochemistry and photobiology.

[56]  S. Snyder,et al.  Carbon monoxide: a putative neural messenger. , 1993, Science.

[57]  Selective necrosis of malignant gliomas in mice using photodynamic therapy. , 1987, British Journal of Cancer.

[58]  Brian C. Wilson,et al.  Theoretical study of the influence of sensitizer photobleaching on depth of necrosis in photodynamic therapy , 1994, Photonics West - Lasers and Applications in Science and Engineering.

[59]  E. Gunter,et al.  Investigation of protoporphyrin IX standard materials used in acid-extraction methods, and a proposed correction for the millimolar absorptivity of protoporphyrin IX. , 1989, Clinical chemistry.

[60]  A. D. Hoyes,et al.  Cerebral photosensitisation by haematoporphyrin derivative. Evidence for an endothelial site of action. , 1986, British Journal of Cancer.

[61]  P Muller,et al.  Photodynamic therapy of brain tumours--post-operative "field fractionation". , 1991, Journal of photochemistry and photobiology. B, Biology.

[62]  W. Potter,et al.  PDT Dosimetry And Response , 1989 .

[63]  A H Kaye,et al.  Photodynamic therapy of brain tumours. , 1993, Annals of the Academy of Medicine, Singapore.

[64]  T. Foster,et al.  Oxygen consumption and diffusion effects in photodynamic therapy. , 1991, Radiation research.